To accomplish this, the expression pattern of SOX2 was evaluated at different stages of oral tumorigenesis, from potentially malignant oral disorders (i.e., oral epithelial dysplastic lesions) to invasive carcinomas, to ascertain its contribution to tumor initiation and malignant transformation, and also late stages of disease progression. The gene discussed is SOX2; the disease is mouth disorder.